Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Onychomycosis | D014009 | — | B35.1 | 2 | 1 | — | — | — | 3 |
Candidiasis | D002177 | — | B37 | — | 1 | — | — | — | 1 |
Vulvovaginal candidiasis | D002181 | EFO_0007543 | B37.3 | — | 1 | — | — | — | 1 |
Vulvovaginitis | D014848 | EFO_1001240 | N76.0 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Tinea | D014005 | EFO_0007510 | B35.9 | 1 | — | — | — | — | 1 |
Tinea pedis | D014008 | EFO_0007512 | B35.3 | 1 | — | — | — | — | 1 |
Drug common name | ALBACONAZOLE |
INN | albaconazole |
Description | Albaconazole (development code UR-9825) is an experimental triazole antifungal. It has potential broad-spectrum activity. The drug blocks a number of CYP450 liver enzymes.
|
Classification | Small molecule |
Drug class | systemic antifungals (miconazole type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[C@@H](n1cnc2cc(Cl)ccc2c1=O)[C@](O)(Cn1cncn1)c1ccc(F)cc1F |
PDB | — |
CAS-ID | 110503-62-3 |
RxCUI | — |
ChEMBL ID | CHEMBL298817 |
ChEBI ID | — |
PubChem CID | 208952 |
DrugBank | — |
UNII ID | YDW24Y8IAB (ChemIDplus, GSRS) |